CHICAGO -- Pfizer has begun a Phase 2 and 3 clinical trial of its COVID-19 antiviral treatment, Paxlovid, in children ages 6 to 17, the company said Wednesday in a news release. The study will ...

The FDA is reportedly considering the addition of high-level warning labels to COVID vaccines, a move that some experts say ...

Long COVID still affects people worldwide with stubborn symptoms like fatigue and cognitive issues. A clinical trial tested ...

NEW YORK -- A course of pills developed by Pfizer can slash the risk of being hospitalized or dying from COVID-19 by 89% if taken within three days of developing symptoms, according to results ...

NEW YORK (WABC) -- With two new pills now authorized by the FDA to fight the effects of COVID, there's a push for New York state to be first in line for the initial shipments. Supplies of Pfizer's ...

Long-term effects after COVID-19 still lack well-documented treatment options. New research may point to a possible answer.

LOS ANGELES (KABC) -- Doctors treating COVID-19 patients are having a difficult time finding new medications designed to keep them out of hospitals. The Food and Drug ...

Federal health regulators say an experimental COVID-19 pill from Merck is effective against the virus, but they will seek input from outside experts on risks of birth defects and other potential ...

New Yorkers will be eligible if they test positive and have symptoms. New York City has begun offering free, same day at-home delivery of COVID-19 antiviral pills to eligible residents although ...